The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 4×
“expression as well as activation of EGFR, are associated with tumour progression and EMT [4].”
BackgroundInfluentialQian, X., Karpova, T., Sheppard, A. M., McNally, J., & Lowy, D. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600136 · Cited by 396 · cited 1×
“On the other hand, E-cadherin inhibits ligand-dependent activation of EGFR [9] (reviewed in Cavallaro 2011 [10]).”
Background
Cited by
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
Peltanova, B., Raudenska, M., & Masarik, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0983-5 · Cited by 469
Chaw, S. Y., Abdul Majeed, A., Dalley, A. J., Chan, A., Stein, S., & Farah, C. S. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.011 · Cited by 302
Betulin and its derivatives as novel compounds with different pharmacological effects
Amiri, S., Dastghaib, S., Ahmadi, M., Mehrbod, P., Khadem, F., Behrouj, H., Aghanoori, M.-R., Machaj, F., Ghamsari, M., Rosik, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.06.008 · Cited by 272
Metadata
- Authors
- Nijkamp, M. M., Span, P. N., Hoogsteen, I. J., van der Kogel, A. J., Kaanders, J. H. A. M., & Bussink, J.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 99
- Issue
- 3
- Pages
- 344-348
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2158172170
- Cited by
- 201
- References
- 3
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.